Who is sponsoring NCT02582307?

NCT02582307 is sponsored by London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's.

What condition does NCT02582307 study?

NCT02582307 studies Abdomen, Acute, Children.

What drugs are being tested in NCT02582307?

Interventions: Acetaminophen, Analgesics, Non-Narcotic, Hyoscine butylbromide, Analgesics, Non-Narcotic.

What is the status of NCT02582307?

NCT02582307 is currently COMPLETED.

Last reviewed 2019-05-02 · How we verify

Buscopan Versus Acetaminophen for Acute Abdominal Pain in Children

NCT02582307 PHASE3 COMPLETED

There is ample evidence that pain in children is under recognized and under treated. This is especially true for acute abdominal pain, a common complaint in the paediatric emergency department. Clinicians often fear that analgesia will obscure the diagnosis of a potentially surgical condition. As a result, acute abdominal pain goes untreated in many children, as there is no standard of care. Hyoscine N-butylbromide (Buscopan) has been used successfully in adults and children for pain associated with urinary tract infections and kidney stones for over 60 years. However, no study has explored its usefulness in relieving acute abdominal pain in children. The objectives of this study are to investigate to what degree Buscopan is effective in relieving abdominal pain in children compared to acetaminophen.

Details

Lead sponsor	London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Phase	PHASE3
Status	COMPLETED
Enrolment	236
Start date	Mon Mar 20 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
Completion	Fri Feb 22 2019 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

Abdomen, Acute
Children

Interventions

Acetaminophen, Analgesics, Non-Narcotic
Hyoscine butylbromide, Analgesics, Non-Narcotic

Countries

Canada